Facebook
X
LinkedIn
Forward
2027 Tutorial on Neoplastic Hematopathology: Moving Toward a Single Classification
Phoenix, AZ US
January 11, 2027 to January 15, 2027
The Tutorial on Neoplastic Hematopathology began over 50 years ago by Dr. Henry Rappaport while at the University of Chicago. After 25 years of outstanding leadership from Dr. Daniel Knowles and Weill Cornell Medicine, the tutorial is now again directed by the University of Chicago under the leadership of Dr. Daniel Arber. Continuing in this tradition, the 5-day 2027 course is designed to update physicians on the latest advances in neoplastic hematopathology. The course remains committed to providing participants the most up-to-date information to patient outcomes and the 2027 course will focus on new disease classifications that were published at the end of 2022 with ongoing expanded publications on how to use the classifications.
Through lectures and case discussions related to the classification of hematopoietic tumors, this activity will improve participants’ skill set of various disease entities. Participants will analyze the clinical, morphologic, immunophenotypic, and molecular genetic changes associated with these disorders and what additional tests are necessary for prognosis and targeted therapy. Participants will be updated on the latest advances in neoplastic hematopathology to improve the diagnosis of harmful and even potentially deadly cancers that include Hodgkin lymphoma, non-Hodgkin lymphoma, plasma cell myeloma, acute and chronic leukemia, myeloproliferative neoplasms, myelodysplastic syndromes, histiocytic tumors, and related disorders. Opportunities to discuss recent advances in the classification of hematopoietic tumors, including clinical and morphologic features, as well as the application and interpretation of immunological and molecular techniques in the diagnosis and classification of these diseases will occur throughout the program.
Target Audience
This activity is designed for pathologists and other healthcare professionals dedicated to the diagnosis of hematological malignancies.
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;
- State how to utilize recent advances in the classification of hematopoietic tumors;
- Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
- Describe how to implement the most recent classification of hematologic neoplasms;
- Recall new discoveries that might impact future classifications of hematologic neoplasms;
- Understand the prognostic and therapeutic significance of new molecular genetic markers of these tumors.
| MONDAY, JANUARY 11, 2027 | ||
|---|---|---|
| Time | Session | Faculty |
| 7:00 AM | REGISTRATION/BREAKFAST | |
| Morning Session Chairperson: Daniel A. Arber, MD | ||
| 8:00 AM | Introductory Remarks | Daniel Arber, MD |
| 8:15 AM | Normal Lymph Nodes and Reactive Hyperplasias | Rebecca King, MD |
| 9:30 AM | Introduction to the Classification of Lymphoma | James Cook, MD |
| 10:15 AM | BREAK | |
| 10:30 AM | Monoclonal B Lymphocytosis, Chronic Lymphocytic Leukemia and Related B-Cell Leukemia | Kathy Foucar, MD |
| 11:45 AM | Questions | |
| 12:00 PM | LUNCH | |
| Afternoon Session Chairperson: Kathy Foucar, MD | ||
| 1:45 PM | Chronic T/NK Cell Leukemias | Kathy Foucar, MD |
| 2:30 PM | Lymphoplasmacytic Lymphoma and Nodal and Extranodal Marginal Zone Lymphoma | James Cook, MD |
| 3:30 PM | Questions | |
| 3:45 PM | BREAK | |
| 4:00 PM | Mantle Cell Lymphoma, Follicular Lymphoma and Variants | Rebecca King, MD |
| 5:00 PM | Case Presentations | James Cook, MD, Kathy Foucar, MD, and Rebecca King, MD |
| 5:45 PM | Questions | |
| 6:00 PM | RECEPTION - The Compass Restaurant | |
| TUESDAY, JANUARY 12, 2027 | ||
| Morning Session Chairperson: Rebecca King, MD | ||
| 7:00 AM | BREAKFAST | |
| 8:00 AM | Peripheral T Cell Lymphoma and Anaplastic Large Cell Lymphoma | Elaine Jaffe, MD |
| 9:30 AM | Questions | |
| 9:45 AM | BREAK | |
| 10:00 AM | Acute Lymphoblastic Leukemias/Lymphoma and Acute Leukemias of Ambiguous Lineage | Michael Borowitz, MD, PhD |
| 11:30 AM | Case Presentations | Michael Borowitz, MD, PhD and Elaine Jaffe, MD |
| 12:00 PM | Questions | |
| 12:15 PM | LUNCH | |
| Afternoon Session Chairperson: Michael J. Borowitz, MD, PhD | ||
| 2:00 PM | Diffuse, Aggressive B Cell Lymphomas | Rebecca King, MD |
| 3:00 PM | Questions | |
| 3:15 PM | BREAK | |
| 3:30 PM | Lymphoma Diagnosis: A Clinician’s Perspective | Javier Munoz, MD, MBA |
| 4:30 PM | Case Presentations | Rebecca L. King, MD |
| 4:45 PM | Questions | |
| WEDNESDAY, JANUARY 13, 2027 | ||
| Morning Session Chairperson: Amy Chadburn, MD | ||
| 7:00 AM | BREAKFAST | |
| 8:00 AM | Immunodeficiency-and Viral-Associated Lymphoproliferations | Jonathan Said, MD |
| 9:15 AM | Splenic Tumors | Daniel Arber, MD |
| 10:00 AM | Questions | |
| 10:15 AM | BREAK | |
| 10:30 AM | Histiocytic Disorders | Amy Chadburn, MD |
| 11:30 AM | Questions | |
| 11:45 AM | LUNCH | |
| Afternoon Session Chairperson: Jonathan Said, MD | ||
| 1:30 PM | Hodgkin Lymphoma | Amy Chadburn, MD |
| 2:30 PM | Questions | |
| 2:45 PM | BREAK | |
| 3:00 PM | Cutaneous Lymphomas | Jonathan Said, MD |
| 4:00 PM | Case Presentations | Amy Chadburn, MD and Jonathan Said, MD |
| 4:30 PM | Questions | |
| THURSDAY, JANUARY 14, 2027 | ||
| Morning Session Chairperson: Adam Bagg, MD | ||
| 7:00 AM | BREAKFAST | |
| 8:00 AM | Introduction to the Classification of Myeloid Neoplasms and Acute Leukemia | Daniel Arber, MD |
| 8:45 AM | Chronic Myeloid Leukemia | Adam Bagg, MD |
| 9:30 AM | Questions | |
| 9:45 AM | BREAK | |
| 10:00 AM | BCR: ABL1--negative Myeloproliferative Neoplasms | Attilio Orazi, MD |
| 11:00 AM | Eosinophilic Disorders | Adam Bagg, MD |
| 11:45 AM | Case Presentations | Adam Bagg, MD and Attilio Orazi, MD |
| 12:15 PM | Questions | |
| 12:30 PM | LUNCH | |
| Afternoon Session Chairperson: Robert Lorsbach, MD | ||
| 1:30 PM | Clonal Cytopenias and Myelodysplastic Syndrome | Robert Hasserjian, MD |
| 2:30 PM | Pediatric and Germline Predisposition Syndromes | Robert Lorsbach, MD |
| 3:15 PM | Questions | |
| 3:30 PM | BREAK | |
| 3:45 PM | Plasma Cell Neoplasms | Robert Lorsbach, MD |
| 4:30 PM | Case Presentations | Robert Hasserjian, MD, and Robert Lorsbach, MD |
| 5:00 PM | Questions | |
| FRIDAY, JANUARY 15, 2027 | ||
| Morning Session Chairperson: Attilio Orazi, MD | ||
| 7:00 AM | BREAKFAST | |
| 9:00 AM | Myelodysplastic/ Myeloproliferative Neoplasms | Attilio Orazi, MD |
| 10:00 AM | Questions | |
| 10:15 AM | BREAK | |
| 10:30 AM | Mastocytosis | Attilio Orazi, MD |
| 11:15 AM | Case Presentations | Daniel Arber, MD and Attilio Orazi, MD |
| 11:45 AM | Questions | |
| 12:00 PM | Concluding Remarks | |
The agenda is subject to change.
Hyatt Regency Phoenix Hotel
122 N 2nd St
Phoenix, AZ
85004
United States
WANT TO KNOW MORE?
For questions about the conference, contact Brittany Dickens via email.
BOOKING INFORMATION
Accommodations have been reserved for Tutorial participants at the Hyatt Regency Phoenix Hotel. Note that a one-night deposit may be required.
To make reservations, follow this LINK: https://www.hyatt.com/events/en-US/group-booking/PHXRP/G-UVPA
To make reservations, follow this LINK: https://www.hyatt.com/events/en-US/group-booking/PHXRP/G-UVPA
Participants may also call 1-888-912-4124 to make reservations and advise the reservations desk that you are attending The University of Chicago Tutorial on Neoplastic Hematopathology from January 11-15, 2027. You should receive the special daily rate of $249/night (single/double). However, we encourage online reservation bookings, as the hotel may charge a booking fee for all reservations made via phone.
Reservations made after December 29, 2026, will be accepted on a space-available basis, and rooms will not be available at the discounted group rate. Therefore, please make your reservations early!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-834-2555 or via email.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
COURSE DIRECTOR
Daniel A. Arber, MD
Donald West and Mary Elizabeth King Professor
Donald West and Mary Elizabeth King Professor
Chair, Department of Pathology
University of Chicago
University of Chicago
ASSOCIATE COURSE DIRECTOR
Attilio Orazi, MD
Professor and Chair, Department of Pathology
Texas Tech University
Professor and Chair, Department of Pathology
Texas Tech University
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Pathology Lifelong Learning (CME) Credit
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 33.75 CME credits. Participants will earn credits equivalent to the amount of 33.75 AMA PRA Category 1 Credits™ claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Lifelong Learning (CME) credit.
Other Participant Credit
Other Participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Pathology Lifelong Learning (CME) Credit
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 33.75 CME credits. Participants will earn credits equivalent to the amount of 33.75 AMA PRA Category 1 Credits™ claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Lifelong Learning (CME) credit.
Other Participant Credit
Other Participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please note: The credit-claiming process will close one month after the activity ends. Requests to claim credit after one month may incur additional fees.
HOW TO REGISTER
Please log in or create an account to register. Once logged in, select the registration type that best suits you. To access early-bird pricing, enter the applicable discount code during registration. Early registration is recommended. For help, view our 
registration guide.
Registration includes daily breakfast, coffee breaks, a welcome reception, and online digital course materials.
Please note registration is for in-person attendance only.
registration guide.Registration includes daily breakfast, coffee breaks, a welcome reception, and online digital course materials.
Please note registration is for in-person attendance only.
Profession Type | Before 11/21/2026 | Discount Code | After 11/21/2026 |
|---|---|---|---|
Practicing Physician | $1750 | TNHE27 | $1850 |
| Other Healthcare Professionals | $1750 | TNHE27 | $1850 |
Physicians in Training | $1000 | TNHE27 | $1100 |
| Industry | $1750 | TNHE27 | $1850 |
CANCELLATION POLICY: If you cancel your participation in this conference, your registration fee less a $150 administrative fee will be refunded when written notification is received by December 31, 2026. No refunds will be made after December 31, 2026. | |||
HOW TO CLAIM CREDIT
At the end of the course, the credit-claiming process will unlock. Return to this page and click on "Complete Activity" to proceed.
Please note: The credit-claiming process will close one month after the activity ends. Requests to claim credit after one month may incur additional fees.
Please note: The credit-claiming process will close one month after the activity ends. Requests to claim credit after one month may incur additional fees.
Please login or create an account to proceed.